Cyclerion Therapeutics (CYCN) Q1 2024 Earnings — Met Estimates

Screener

Reported March 25, 2026

Revenue$100.0KIn line

EPS-$0.38In line

Revenue estimate$100.0K

EPS estimate-$0.38

Next report

Nov 11, 2026 (in 2 months)

Revenue estimate$900.0K

EPS estimate-$6.00

Versus estimates

Revenue

Q4 2025$100.0KIn line

Q1 2024$100.0KIn line

Q3 2025$875.0K Q2 2025$93.0K

Diluted EPS

Q2 2026-$0.41Beat by $6.69 Q1 2026-$0.76Beat by $16.44 Q4 2025-$0.19Beat by $0.19

Q1 2024-$0.38In line

Q3 2025-$0.30 Q2 2025-$0.11

FAQ

When did Cyclerion Therapeutics report Q1 2024 earnings?: Cyclerion Therapeutics (CYCN) reported Q1 2024 earnings on March 25, 2026.
What were Cyclerion Therapeutics's Q1 2024 revenue and EPS?: Cyclerion Therapeutics reported revenue of $100.0K and eps of $-0.38 for Q1 2024.
Did Cyclerion Therapeutics beat estimates in Q1 2024?: Revenue beat the consensus estimate of $100.0K by -. EPS beat the consensus estimate of $-0.38 by $0.00.
Where can I find Cyclerion Therapeutics's Q1 2024 SEC filings?: You can read the 10-Q periodic report (0000950170-24-054602) directly on SEC EDGAR. The filing index links above go to sec.gov.

Ask the moment Cyclerion Therapeutics reports.

Connect your AI and ask the moment the filing drops. It reads the release, surfaces what management said, and gives you its own read.

Connect your AI

Harbor at dusk